Drug Metabolism May Be Suppressed in Patients with Inflammatory Conditions
Suppressed drug metabolism was identified in patients with various inflammatory conditions.
Suppressed drug metabolism was identified in patients with various inflammatory conditions.
Findings may help with decision-making in this high-risk patient population.
The main outcome of the study was hospital presentation due to serious hypoglycemia.
Currently, ACE inhibitors and ARBs are both recommended as first-line therapies for the treatment of hypertension according to US and European guidelines.
Each additional cup of habitual coffee consumed reduced the risk of incident arrhythmia by 3%.
Despite an increasing emphasis on HFmrEF over the past several years, there is a lack of authoritative guidance surrounding therapeutic approaches for these patients.
Small increases in the risk for statin-associated muscle symptoms were observed for patients on high-intensity therapy.
Study findings revealed an increased risk of surgical intervention in women exposed to rivaroxaban.
While known to increase patient compliance, medication organizers, such as blister packs and pill boxes, have also been associated with unintentional pediatric medication exposures.
Omega-3 fatty acids, including eicosapentaenoic acid (EPA) and docosehexaenoic acid (DHA), have been found to be associated with cardiovascular health benefits.